BriaCell develops ovarian cancer immunotherapy candidate

Go back to BriaCell develops ovarian cancer immunotherapy candidate
(NASDAQ: BCTX) Delayed: 2.90 --0 (-0%)
Previous Close $2.90    52 Week High
Open $2.90    52 Week Low
Day High $2.90    P/E N/A 
Day Low $2.90    EPS
Volume 104